ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
34.65
-0.26%
US Tech 100
19,168.00
0.52%
S&P 500
5,431.60
-0.04%
US Dollar vs CAD
1.37435
-0.06%
Bitcoin
66,486.76
-0.23%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Myriad Genetics Inc (MYGN)

  7. Myriad Genetics Inc (MYGN) News

MYGN

Myriad Genetics (MYGN)

Myriad Genetics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MYGN
DateTimeSourceHeadlineSymbolCompany
06/11/20247:00AMGlobeNewswire Inc.Myriad Genetics Collaborates with GSK to Improve Access to HRD Testing in 9 CountriesNASDAQ:MYGNMyriad Genetics Inc
06/10/20243:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MYGNMyriad Genetics Inc
06/07/20243:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MYGNMyriad Genetics Inc
06/07/20243:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MYGNMyriad Genetics Inc
06/07/20243:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MYGNMyriad Genetics Inc
06/07/20243:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MYGNMyriad Genetics Inc
06/07/20243:53PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MYGNMyriad Genetics Inc
06/07/20243:53PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MYGNMyriad Genetics Inc
06/07/20243:53PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MYGNMyriad Genetics Inc
06/06/20243:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MYGNMyriad Genetics Inc
06/04/20244:57PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MYGNMyriad Genetics Inc
06/04/20249:32AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MYGNMyriad Genetics Inc
06/04/20248:00AMGlobeNewswire Inc.Myriad Genetics Launches New Universal Plus Panel for Foresight® Carrier ScreenNASDAQ:MYGNMyriad Genetics Inc
06/03/20243:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MYGNMyriad Genetics Inc
06/03/20243:05PMGlobeNewswire Inc.Genetics in Medicine Publishes Myriad Genetics Patient-Outcomes Study Validating RiskScore® as a Clinical Breast Cancer Risk Assessment ToolNASDAQ:MYGNMyriad Genetics Inc
06/03/202412:48PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MYGNMyriad Genetics Inc
05/30/20244:55PMGlobeNewswire Inc.QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applicationsNASDAQ:MYGNMyriad Genetics Inc
05/23/20245:00PMGlobeNewswire Inc.Myriad Genetics Showcases New Research and Product Innovations Advancing Cancer Care at 2024 ASCO® Annual MeetingNASDAQ:MYGNMyriad Genetics Inc
05/16/20243:05PMGlobeNewswire Inc.New Study Published in JCO Precision Oncology Shows Myriad Genetics' Prolaris Test Can Predict Benefit of Hormone Therapy Treatment in Men with Localized Prostate CancerNASDAQ:MYGNMyriad Genetics Inc
05/15/20244:49PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MYGNMyriad Genetics Inc
05/15/20244:48PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MYGNMyriad Genetics Inc
05/15/20243:24PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MYGNMyriad Genetics Inc
05/14/20243:26PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MYGNMyriad Genetics Inc
05/13/20243:24PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MYGNMyriad Genetics Inc
05/13/202411:14AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MYGNMyriad Genetics Inc
05/08/20247:23AMIH Market NewsReddit Rises 15% After First Quarterly Report, Upstart and Twilio Plunge Due to Weak Q2 Forecast, and More in EarningsNASDAQ:MYGNMyriad Genetics Inc
05/08/20247:14AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MYGNMyriad Genetics Inc
05/07/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MYGNMyriad Genetics Inc
05/07/20243:05PMGlobeNewswire Inc.Myriad Genetics Reports Strong First Quarter 2024 Financial Results; Achieves 12% Revenue Growth Year-Over-Year; Significantly Improved Year-Over-Year Net Loss and Generated Positive Adjusted EBITDANASDAQ:MYGNMyriad Genetics Inc
05/07/20248:00AMGlobeNewswire Inc.Myriad Genetics Announces Reorganization of European Operations and Sale of EndoPredict BusinessNASDAQ:MYGNMyriad Genetics Inc
 Showing the most relevant articles for your search:NASDAQ:MYGN

Your Recent History

USOTC
CNNA
Cann American (CE)
USOTC
HHSE
Hannover House (PK)
USOTC
VXIT
Virexit Technologies (PK)
USOTC
ERHE
ERHC Energy (CE)
USOTC
DBMM
Digital Brand Media and ... (PK)
USOTC
RNVA
Rennova Health (PK)
USOTC
RONN
Ronn Motor (PK)
USOTC
ELTP
Elite Pharmaceuticals (QB)
NASDAQ
COOP
Mr Cooper
NASDAQ
AVXL
Anavex Life Sciences
USOTC
CIVX
CTR Investments and Cons... (PK)
USOTC
NWBO
Northwest Biotherapeutics (QB)
USOTC
SMCE
SMC Entertainment (PK)
USOTC
FNMA
Fannie Mae (QB)
USOTC
SPZI
Spooz (PK)
NASDAQ
DJT
Trump Media and Technology
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved